The FDA rejected an application for the drug MDMA, in combination with therapy, as treatment for PTSD on Friday.

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen they argued could be a breakthrough for treating challenging cases of PTSD. Lykos said the ...

A U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic stress disorder (PTSD) that are often used in veteran care. On June 4, the advisory committee ...

Advocates say drugs such as MDMA can treat mental health disorders and have therapeutic applications beyond their illicit use.

There are only two FDA-approved treatments for PTSD and MDMA would be the first to come on the market in decades. It would also be a milestone for the broader effort to expand access to psychedelics.

The U.S. Food and Drug Administration (FDA) announced Friday its rejection of MDMA as a treatment for PTSD. The decision was based on "significant limitations" that "prevent the agency from ...

In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks.

If approved, MDMA-AT would be the first psychedelic-based therapeutic cleared by the FDA for any condition in the US and the first PTSD medication to receive approval in 24 years. FDA officials ...

There are only two FDA-approved treatments for PTSD. MDMA would be the first to come on the market in decades. Though classified as a Schedule I drug, the FDA granted MDMA "breakthrough therapy ...

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...